Malaria is a life-threatening disease that is transmitted
through the bite of infected anopheles mosquitos. The infected mosquitos
transmit the plasmodium parasite into the bloodstream of human body upon being
bitten. As the parasite enters the human body, it travels around the body to
affect the liver and matures with time. Upon attaining maturity, the parasite
enters the bloodstream to infect the red blood cells in the body. This causes
individuals suffering from malaria to frequently experience headache, vomiting,
fever, and weakness.
Africa Malaria
Diagnosis & Treatment Market Overview analysis, by Diagnosis (Rapid
Diagnostic Tests (RDT’s), Molecular diagnostics, Microscopy), by Malarial
Parasite (Plasmodium Falciparum, Plasmodium Vivax, Plasmodium Malariae and
Plasmodium Ovale) - Forecast till 2030
The Africa malaria diagnosis & treatment market is
projected to reach USD 2,467.6 Million by 2030 at 6.9% CAGR during the forecast
period 2022-2030.It is reported in a study released by Market Research Future
(MRFR), that the market is positively influenced by a number of factors. A
major factor influencing this growth is the increasing advancements in
technology related to diagnostic tools and the proliferating demand for such
treatments in malaria-endemic countries. Other factors driving the market
growth are rising support from the government in terms of investment funds and
an increase in the collaboration between the research centers and the industry.
Malaria diagnostic tests play a significant role in identifying malarial cases,
which thereby boosts the growth of the overall malaria diagnostic market.
However, the lack of precise monitoring standards at
developing nations, acts as a major factor constraining the market. The lack of
awareness among emerging nations and work regulatory framework is of particular
concern for both manufacturers and healthcare providers.
Market Segmentation
The global malaria diagnostics market segmentation is done
as per technology and end-user.
By technology, the market is divided into microscopy,
molecular diagnostic tests, and rapid diagnostic tests. Furthermore, the
molecular diagnostic test is narrowed down into real-time polymerase chain
reaction (RT-PCR) and polymerase chain reaction (PCR).
By end-users, the market comprises of clinics, hospitals,
community healthcare, and others.
Regional Analysis
Geographically, the global malaria diagnostic market covers
regions such as North America, European, Asia Pacific, and Middle East &
Africa.
The North American region holds the largest share of the malaria
diagnostic market Report and leads the global standings. The region is
further expected to garner the largest market share during the forecast period
2018 and 2023. The market is slated for growth due to the rise in awareness,
advancing medical technologies, favorable compensation setting for various
surgical methods and procedures, medical tourism, and expanding growth of the
healthcare sector.
Competitive Landscape
The global malaria diagnostics market comprises of a number
of key and prominent players, including Leica Microsystems GmbH, Premier
Medical Corporation Pvt. Ltd, Access Bio. Inc., Beckman Coulter Inc.,
bioMérieux, Nikon Corporation, Abbott Laboratories, Olympus Corporation, Sysmex
Partec GmbH, Siemens Healthineers, and Bio-Rad Laboratories Inc.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
The Wall